Full text is available at the source.
Abstract
Liraglutide treatment lowered glucose levels in mice lacking GLP1 receptors in the brain and visceral nerves.
- Both glucose levels and body weight are regulated by the brain through GLP1 receptors.
- Mice with specific deletions of GLP1 receptors in neurons or visceral nerves showed no change in body weight or food intake with liraglutide treatment.
- Liraglutide effectively reduced glucose levels in chow- and high-fat-fed mice, regardless of GLP1 receptor presence in the CNS or visceral nerves.
- Neuronal GLP1 receptors are associated with the body weight and appetite-suppressing effects of liraglutide.
- GLP1 receptors in the brain are not necessary for the glucose-lowering effects of liraglutide.
Simplified